The goal of this clinical trial is to evaluate whether an opioid-sparing postoperative pain regimen can reduce opioid consumption and maintain effective pain control in adults undergoing anterior total hip arthroplasty for osteoarthritis. The main questions it aims to answer are: * Does an opioid-limited regimen result in lower postoperative opioid use compared with a standard opioid prescription? * Does the opioid-limited regimen provide comparable or improved postoperative pain control and patient satisfaction?
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Daily Pain Scores (Numeric Rating Scale, NRS)
Timeframe: Postoperative Days 1-7
Opioid Consumption (Morphine Milligram Equivalents, MME)
Timeframe: 1 week, 3 weeks, and 3 months postoperatively
Pain-Related Contacts to Clinical Team
Timeframe: Up to 3 months postoperatively
Medication-Related Side Effects
Timeframe: Postoperative Days 1-7
Opioid Prescription Refills
Timeframe: Up to 3 months postoperatively
Patient Satisfaction With Pain Control
Timeframe: 1 week, 3 weeks, and 3 months